• Info
  • Insider Ownership

Insider Trading & Ownership of PAUL R. FONTEYNE

Location
Boston, MA
Summary
The estimated net worth of PAUL R. FONTEYNE is at least $1,105,729 dollars as of 05 Jan 2026. PAUL R. FONTEYNE is the Director of Apellis Pharmaceuticals, Inc. and owns shares of Apellis Pharmaceuticals, Inc. (APLS) stock worth about $1.11M.
Signature
/s/ David Watson, attorney-in-fact for Paul Fonteyne
All Insider Reports
All Insider Reports

Notify me when PAUL R. FONTEYNE files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of PAUL R. FONTEYNE

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
APLS Apellis Pharmaceuticals, Inc. Director $1,105,729 01 Jan 2026
AMLX Amylyx Pharmaceuticals, Inc. Director 05 Jun 2025
CVET COVETRUS, INC. Director 13 Oct 2022
GLSH GELESIS HOLDINGS, INC. Director 06 May 2022

Insider Transactions Reported by PAUL R. FONTEYNE:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.